Skip to main content
Premium Trial:

Request an Annual Quote

As Expected, Nasdaq to Delist Tripos 'Shell' From Stock Market

NEW YORK (GenomeWeb News) — As expected, the Nasdaq Stock Market said it plans to file a petition with the US Securities and Exchange Commission to delist Tripos, the market said today.
 
Nasdaq said the delisting will become effective 10 days after the filing. Tripos has not traded on the Nasdaq since July 6, when the market suspended its stock.
  
Tripos said at the time that the delisting was expected. The company had recently sold its Discovery Research business and had become a public shell, making its stock ineligible for listing on the Nasdaq.
  
Tripos also said in July it plans to seek to trade on the Nasdaq’s Over-the-Counter Bulletin Board, and that its stock will be available for quotation on the Pink Sheets electronic quotation service.
 
 
The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.